Provention Bio Stock Predictions

Healthcare > Biotechnology

Buy PRVB

*Your capital is at risk

$24.98

+0 (+0%)

At Close: Jul 24, 2023

Currently predicting for Mon, 8 Jun 2026

PRVB Prediction Chart

PRVB Predictions History

Latest community submissions for PRVB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Derek132083	Jan 21, 2020	Bearish	$17.75	X	—	0
Michael Tyler Merchant @MichaelTyler.131297	Jan 7, 2020	Bearish	$14.97	X	—	0
JS Pro	Dec 30, 2019	$13.91 -1.70%	$14.15	X	98.30%	1
2poJeff Pro	Dec 30, 2019	$14.72 +4.03%	$14.15	X	95.97%	0
Dan Lynch @DanLynch.131526	Dec 30, 2019	Bearish	$14.15	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PRVB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PROVENTION BIO INC.

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by